228 related articles for article (PubMed ID: 9118515)
21. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
23. Serum aldosterone effect on left ventricular structure and diastolic function in essential hypertension.
Al-Hashedi EM; Zhao X; Mohammed AA; Juvenal H; Yu J
J Clin Hypertens (Greenwich); 2023 Feb; 25(2):213-222. PubMed ID: 36585812
[TBL] [Abstract][Full Text] [Related]
24. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
[TBL] [Abstract][Full Text] [Related]
26. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
[TBL] [Abstract][Full Text] [Related]
27. [Primary hyperaldosteronism--12 clinical cases].
Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
[TBL] [Abstract][Full Text] [Related]
28. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.
Pimenta E; Gordon RD; Ahmed AH; Cowley D; Leano R; Marwick TH; Stowasser M
J Clin Endocrinol Metab; 2011 Sep; 96(9):2813-20. PubMed ID: 21632817
[TBL] [Abstract][Full Text] [Related]
29. Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
Cesari M; Letizia C; Angeli P; Sciomer S; Rosi S; Rossi GP
Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27307552
[TBL] [Abstract][Full Text] [Related]
30. Malignant hypertension due to an aldosterone producing adrenal adenoma.
Murphy BF; Whitworth JA; Kincaid-Smith P
Clin Exp Hypertens A; 1985; 7(7):939-50. PubMed ID: 3899416
[TBL] [Abstract][Full Text] [Related]
31. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.
Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC
Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224
[TBL] [Abstract][Full Text] [Related]
32. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension.
Yoshihara F; Nishikimi T; Yoshitomi Y; Nakasone I; Abe H; Matsuoka H; Omae T
Am J Hypertens; 1996 Jun; 9(6):523-8. PubMed ID: 8783775
[TBL] [Abstract][Full Text] [Related]
34. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
35. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension.
Iwashima Y; Horio T; Kuroda S; Takishita S; Kawano Y
Hypertens Res; 2002 Jan; 25(1):49-56. PubMed ID: 11924725
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular filling profiles and angiotensin system activity in elite baseball players.
Lai ZY; Chang NC; Tsai MC; Lin CS; Chang SH; Wang TC
Int J Cardiol; 1998 Dec; 67(2):155-60. PubMed ID: 9891949
[TBL] [Abstract][Full Text] [Related]
37. [Cardiac consequences of primary hyperaldosteronism].
du Cailar G
Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):147-9. PubMed ID: 15291171
[TBL] [Abstract][Full Text] [Related]
38. Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension.
Chang YY; Lee HH; Hung CS; Wu XM; Lee JK; Wang SM; Liao MT; Chen YH; Wu VC; Wu KD; Lin YH;
Clin Biochem; 2014 Sep; 47(13-14):1329-32. PubMed ID: 24892901
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.
Tanabe A; Naruse M; Naruse K; Hase M; Yoshimoto T; Tanaka M; Seki T; Demura R; Demura H
Hypertens Res; 1997 Jun; 20(2):85-90. PubMed ID: 9220271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
